Project

Rituximab, bendamustine and lenalidomide in patients with relapsed or refractory aggressive B-cell lymphoma not eligible for high dose chemotherapy. A phase I/II trial

Automatically Closed · 2009 until 2012

Hitz Felicitas, Driessen Christoph